Balaji Amines Ltd
NSE:BALAMINES

Watchlist Manager
Balaji Amines Ltd Logo
Balaji Amines Ltd
NSE:BALAMINES
Watchlist
Price: 1 949.6 INR -0.24% Market Closed
Market Cap: 63.2B INR
Have any thoughts about
Balaji Amines Ltd?
Write Note

Balaji Amines Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Balaji Amines Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Balaji Amines Ltd
NSE:BALAMINES
Total Liabilities & Equity
â‚ą21.5B
CAGR 3-Years
10%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Akzo Nobel India Ltd
NSE:AKZOINDIA
Total Liabilities & Equity
â‚ą29B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Navin Fluorine International Ltd
NSE:NAVINFLUOR
Total Liabilities & Equity
â‚ą43.8B
CAGR 3-Years
28%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Asian Paints Ltd
NSE:ASIANPAINT
Total Liabilities & Equity
â‚ą294.7B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
13%
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
Total Liabilities & Equity
â‚ą92.3B
CAGR 3-Years
16%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Vinati Organics Ltd
NSE:VINATIORGA
Total Liabilities & Equity
â‚ą30.3B
CAGR 3-Years
18%
CAGR 5-Years
18%
CAGR 10-Years
17%
No Stocks Found

Balaji Amines Ltd
Glance View

Market Cap
63.2B INR
Industry
Chemicals

Balaji Amines Ltd. manufactures, sells and exports methylamines, ethylamines and derivatives of specialty chemicals and pharma excipients in India. The company is headquartered in Secunderabad, Telangana and currently employs 1,071 full-time employees. The firm is running a five-star hotel in Solapur, Maharashtra, namely Balaji Sarovar Premiere. The firm operates through three segments: Specialty Chemicals and Amines, Hotel and CFL Lamps. Its amines products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA) and TRIMETHYLAMINE (TMA). Its specialty chemicals include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE (2-P), N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and DIMETHYLFORMAMIDE (DMF). Its derivatives include Di-Methyl Acetamide (DMAC), Di-Ethyl Amine Hydrochloride (DMA HCL), Tri-Ethyl Amine Hydrochloride (TEA HCL), Di-Ethyl Amine Hydrochloride (DEA HCL) and Tri-Methyl Amine Hydrochloride (TMA HCL). Its pharma excipients include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.

BALAMINES Intrinsic Value
2 505.4 INR
Undervaluation 22%
Intrinsic Value
Price

See Also

What is Balaji Amines Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
21.5B INR

Based on the financial report for Sep 30, 2024, Balaji Amines Ltd's Total Liabilities & Equity amounts to 21.5B INR.

What is Balaji Amines Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
17%

Over the last year, the Total Liabilities & Equity growth was 8%. The average annual Total Liabilities & Equity growth rates for Balaji Amines Ltd have been 10% over the past three years , 17% over the past five years .

Back to Top